KO

Business Context and Reporting Period

This Form 10-Q covers The Coca-Cola Company for the quarterly period ended March 31, 2003. The Company operates globally across six segments: North America, Africa, Europe/Eurasia/Middle East, Latin America, Asia, and Corporate. The first quarter is typically a lower-volume period due to seasonality in the Northern Hemisphere, though results were impacted by strategic acquisitions, currency fluctuations, and specific regional disruptions.

Key Financial Metrics

Margins: Gross margin decreased to 64.4% in Q1 2003 from 65.8% in Q1 2002. Operating margin decreased to 23.9% from 28.4%.

Material Changes vs. Prior Period

• Revenue Growth: Net operating revenues increased 10% ($419 million) driven by a 7% increase in gallon shipments, structural changes (inclusion of an additional month of revenue from German bottler CCEAG), and a 2% favorable impact from a weaker U.S. dollar.
• Operating Income Decline: Despite revenue growth, operating income fell 7% ($82 million). This was primarily due to $159 million in "Other Operating Charges" related to streamlining initiatives and increased stock-based compensation ($19 million).
• Net Income Volatility: Q1 2002 Net Income was a loss of $194 million, heavily impacted by a one-time cumulative effect of accounting change (SFAS No. 142) totaling $926 million. Q1 2003 Net Income of $835 million excludes such charges.
• Cash Flow: Operating cash flow decreased $362 million year-over-year, attributed to a $145 million funding of an employee retirement plan and the absence of a $280 million tax receivable collection that occurred in Q1 2002.

Guidance, Outlook, and Risks

Management Commentary and Outlook

• Volume Growth: Worldwide unit case volume increased 4% in Q1 2003. International operations grew 4%, while North America grew 3%.
• Streamlining Initiatives: The Company initiated cost-saving measures in North America and Germany. Total expected charges for 2003 are approximately $400 million (pretax), with $159 million already recorded in Q1. These initiatives are expected to yield annualized savings of at least $100 million starting in 2004.
• Capital Allocation: The Company estimates share repurchases will total approximately $1.5 billion in 2003. Capital expenditures for property, plant, and equipment are estimated at $1 billion for the full year.
• Exchange Rates: The U.S. dollar was 6% weaker in Q1 2003. Management expects exchange rates to have a neutral to slightly positive impact on Operating Income for the remainder of 2003.

Risks and Contingencies

• Geopolitical Instability: Operations in the Middle East (war in Iraq), Venezuela (strikes/political turmoil), and Germany (deposit law on non-returnable packages) have had adverse short-term impacts. Management currently believes these are temporary and have not resulted in asset impairments.
• Legal Proceedings: The Company is involved in various litigation, including a vitamin antitrust matter (settled for $52 million in Q1 2003) and an asbestos-related dispute with a former subsidiary (Aqua-Chem) where the Company disputes liability.
• Accounting Changes: The Company adopted SFAS No. 146 regarding exit costs and is evaluating the impact of FASB Interpretation No. 46 on the consolidation of variable interest entities (bottlers), effective July 1, 2003.

Investor Verification Checklist

• Verify the sustainability of the 4% unit case volume growth given the headwinds in the Middle East and Venezuela.
• Monitor the execution of the $400 million streamlining charge and the realization of the projected $100 million annualized savings.
• Assess the impact of the German deposit law on long-term market share in Europe.
• Review the status of the Aqua-Chem asbestos litigation and potential exposure beyond the disputed $10 million demand.
• Confirm the timeline and financial impact of the potential consolidation of bottling entities under FASB Interpretation No. 46.